Trastuzumab Completed Phase 2 Trials for Stage IV Breast Cancer / Male Breast Cancer / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00004888Combination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00024154Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer